The Development of Fulminant Type 1 Diabetes during Chemotherapy for Rectal Cancer
Author:
Affiliation:
1. Department of Internal Medicine, Ohkubo Hospital, Japan
2. Department of Diabetes and Endocrinology, Yokohama City Minato Red Cross Hospital, Japan
3. Diabetes Center, Ebina General Hospital, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Reference21 articles.
1. 1. Hanafusa T, Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab 3: 36-45, 2007.
2. 2. Tanaka S, Nishida Y, Aida K, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated-cell failure in fulminant type 1 diabetes. Diabetes 58: 2285-2291, 2009.
3. 3. Imagawa A, Hanafusa T. Fulminant type 1 diabetes: an important subtype in East Asia. Diabetes Metab Res Rev 27: 959-964, 2011.
4. 4. Takeda H, Kawasaki E, Shimizu I, et al. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care 25: 995-1001, 2002.
5. 5. Imagawa A, Hanafusa T, Uchigata Y, et al. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 48: 294-300, 2005.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Associations between Diabetes Mellitus and Selected Cancers;International Journal of Molecular Sciences;2024-07-08
2. The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms;Frontiers in Endocrinology;2022-02-11
3. Current cancer therapies and their influence on glucose control;World Journal of Diabetes;2021-07-15
4. Capecitabine-induced hyperosmolar hyperglycaemic state;BMJ Case Reports;2021-03
5. Diabetic ketoacidosis caused by fulminant type 1 diabetes during adjuvant chemotherapy for colon cancer: A case report;Molecular and Clinical Oncology;2019-05-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3